Here's Why CVS Health (CVS) is a Strong Growth Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
CVS - CVS Health Corp.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$111.20
DETAILS
HIGH:
$123.00
LOW:
$92.00
MEDIAN:
$112.00
CONSENSUS:
$111.20
UPSIDE:
25.81%
Stock News
Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks Delivering High-Dividend Yields
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high dividend payout.
CVS Health (CVS) Advances While Market Declines: Some Information for Investors
In the closing of the recent trading day, CVS Health (CVS) stood at $87.95, denoting a +1.76% move from the preceding trading day.
Suze Orman Warned 390,000 People Their Medicare Plans Are Shutting Down, Then CNBC Called the Same Stock a Turnaround
On October 4, Suze Orman, the personal finance author and former CNBC host, had a warning for her podcast listeners covered by UnitedHealth Group (NYSE: UNH): "If you have UnitedHealth Group, about 390,000 people are part of plans that are shutting down." She said Humana (NYSE: HUM) will cut plans covering about 600,000 people. She also said
CVS Pharmacy® celebrates opening of first pharmacy-focused location in Boston area
Pharmacy-focused sites are opening in select communities to help increase access to pharmacy care WOONSOCKET, R.I., Oct. 7, 2026 /PRNewswire/ -- CVS Health® (NYSE: CVS) today unveiled its first pharmacy-focused CVS Pharmacy® in the Boston area.
Is Most-Watched Stock CVS Health Corporation (CVS) Worth Betting on Now?
CVS Health (CVS) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Why CVS Is ‘Insanely Cheap,' ON Semi a Laggard Catching Up, and Grail Too Expensive to Chase
Jim Cramer sees three stocks with very different amounts of bad news or good news already baked into their prices, and figuring out which side each sits on changes everything about whether to buy.
CVS Health® reminds New Yorkers that MMR vaccines are available statewide amid measles outbreak
Eligible patients can receive MMR vaccinations at more than 530 CVS Pharmacy® locations across New York and at MinuteClinic® locations WOONSOCKET, R.I., Oct. 7, 2026 /PRNewswire/ -- As New York responds to an ongoing measles outbreak and statewide disaster emergency, CVS Health® (NYSE: CVS) is reminding residents that measles-mumps-rubella (MMR) vaccinations are available for eligible patients at CVS Pharmacy® and MinuteClinic® locations across the state.
CVS' Health Care Benefits Arm Shows Better Core Trends: What's Ahead?
CVS Health raises its Health Care Benefits outlook as stronger core trends, led by Medicare, support margin recovery despite medical cost pressures.
Her Doctor Used to File Four Prior Authorizations for One Cancer Case. Aetna Medicaid Is Folding Them Together in 8 States
A lymphoma patient on Medicaid can face four separate insurance permission slips before her first treatment begins, and every one of those gates is a chance for her care to stall. Aetna is rethinking that process in eight states, but the details buried in the fine print still catch families off guard.
CVS Health Corporation $CVS Stock Position Trimmed by Park National Corp OH
Park National Corp OH reduced its stake in CVS Health Corporation (NYSE: CVS) by 4.4% during the third quarter, according to its most recent filing with the SEC. The fund owned 132,587 shares of the pharmacy operator's stock after selling 6,031 shares during the quarter. Park National Corp OH's holdings in CVS Health
Will CVS Health (CVS) Beat Estimates Again in Its Next Earnings Report?
CVS Health (CVS) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
CVS Health Corporation $CVS Stock Acquired by Argent Capital Management LLC
Argent Capital Management LLC grew its position in shares of CVS Health Corporation (NYSE: CVS) by 50.4% during the third quarter, according to its most recent filing with the SEC. The firm owned 238,110 shares of the pharmacy operator's stock after acquiring an additional 79,822 shares during the period. Argent Capital Management LLC's
Looking for Stocks with Positive Earnings Momentum? Check Out These 2 Medical Names
Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
CVS Health to hold third quarter 2026 earnings conference call
WOONSOCKET, R.I., Oct. 5, 2026 /PRNewswire/ -- CVS Health® (NYSE: CVS) will hold a conference call with analysts and investors on Wednesday, November 4, 2026, at 8:00 a.m.
Aetna 2027 Medicare plans offer reliable, affordable access to care & member support
Aetna 2027 Medicare plans offer reliable, affordable access to care and member supportPR NewswireWOONSOCKET, R.I., Oct. 3, 2026Plans designed to provide member va
Aetna 2027 Medicare plans offer reliable, affordable access to care & member support
Plans designed to provide member value and access to care: $0 copays on Tier 1 drugs and covered vaccines at in-network pharmacies* $0 copays for annual physicals, colonoscopies and mammograms at in-network providers $0 copays for annual Healthy Home Visit from a licensed Signify Health clinician Dental, vision and hearing benefits A continued focus on affordability, quality care and preserving the benefits that matter most to members through an expanded HMO portfolio and market-leading coverage of generic drugs Targeted care for high-needs members with chronic conditions and those dually eligible for Medicare and Medicaid Award-winning guidance and support for our members delivered through our dedicated service teams and market-leading digital tools WOONSOCKET, R.I., Oct. 3, 2026 /PRNewswire/ -- Aetna®, a CVS Health® company (NYSE: CVS), today announced our 2027 Medicare products with choices designed to support older adults with a wide range of health needs, providing reliable benefits that enable affordability and access to quality care.
These 3 Dividend Stocks Yield Less Than 10-Year Treasuries Over 5%. Here's Why They Are Better Buys Anyway.
Treasuries pay more today, but these three healthcare dividend payers offer something Treasuries can't: growth in both the payout and the stock.
CVS Health declares quarterly dividend
WOONSOCKET, R.I., Sept. 30, 2026 /PRNewswire/ -- CVS Health® (NYSE: CVS) has announced that its board of directors has approved a quarterly dividend of sixty-six and one-half cents ($0.665 cents) per share on the Common Stock of the Corporation.
CVS Health (CVS) Falls More Steeply Than Broader Market: What Investors Need to Know
The latest trading day saw CVS Health (CVS) settling at $87.85, representing a -1.44% change from its previous close.
Price Targets
CVS Health (CVS) PT Raised to $112 at Bernstein SocGen Group
$112.00
(was $93.05)
Piper Sandler
CVS Health (CVS) PT Raised to $112 at Bernstein SocGen Group
$112.00
(was $93.05)
Bernstein
CVS Health (CVS) PT Raised to $112 at Bernstein SocGen Group
$112.00
(was $93.05)
BMO Capital
CVS Health price target lowered to $118 from $126 at UBS
$118.00
(was $97.23)
UBS
CVS Health price target raised to $114 from $104 at Argus
$114.00
(was $95.58)
Argus Research
CVS Health price target raised to $107 from $94 at Baird
$107.00
(was $96.95)
Michael Ha
·
Robert W. Baird
CVS Health (CVS) PT Raised to $126 at UBS
$126.00
(was $99.12)
Kevin Caliendo
·
UBS
CVS Health price target raised to $108 from $106 at Barclays
$108.00
(was $99.12)
Barclays
CVS Health price target raised to $122 from $115 at UBS
$122.00
(was $107.85)
UBS
CVS Health price target raised to $118 from $108 at Truist
$118.00
(was $105.90)
David MacDonald
·
Truist Financial
CVS Health price target raised to $123 from $103 at Wells Fargo
$123.00
(was $104.15)
Wells Fargo
CVS Health price target raised to $113 from $107 at RBC Capital
$113.00
(was $104.83)
RBC Capital
CVS Health (CVS) PT Raised to $110 at Cantor Fitzgerald Post ChecksMember Login
$110.00
(was $102.08)
Cantor Fitzgerald
CVS Health price target raised to $103 from $85 at HSBC
$103.00
(was $102.28)
HSBC
CVS Health price target raised to $115 from $110 at Mizuho
$115.00
(was $95.93)
Mizuho Securities
CVS Health price target raised to $111 from $106 at Morgan Stanley
$111.00
(was $91.37)
Morgan Stanley
CVS Health price target raised to $108 from $102 at Truist
$108.00
(was $90.98)
Truist Financial
Piper Sandler Reiterates Overweight Rating on CVS Health (CVS)
$113.00
(was $90.98)
Jessica Tassan
·
Piper Sandler
CVS Health price target raised to $106 from $101 at Barclays
$106.00
(was $91.63)
Andrew Mok
·
Barclays
CVS Health price target raised to $110 from $102 at Mizuho
$110.00
(was $94.18)
Mizuho Securities